Creative Biolabs is advancing Adenoviral Vector innovation for gene therapy
Creative Biolabs, providers of integrated solutions encompassing viral vector design, construction, production, purification, and quality control, is expanding its end-to-end viral vector design and development solutions.
With decades of expertise across lentiviral, adenoviral, and adeno-associated virus (AAV) platforms, Creative Biolabs offers tailored gene-delivery strategies. Its viral vector services are built on a modular framework that supports serotype selection, promoter optimisation, payload customisation, and scalable manufacturing, ensuring precision and flexibility across diverse research pipelines.
Adenoviral vectors, in particular, have emerged as indispensable tools due to their high transduction efficiency, large packaging capacity (up to 36kb in helper-dependent formats), and robust gene expression. Creative Biolabs stands out by offering custom adenoviral solutions that meet both research-grade and GMP-level standards.
A spokesperson from Creative Biolabs, said, “The adenoviral platform has been developed to handle the most challenging research and clinical needs. Whether we are dealing with first-generation constructs that are fundamentally short-term expression, or third-generation helper-dependent systems with a diminished immunogenic profile, we can provide custom solutions that speed research and development processes.”
The adenoviral services from Creative Biolabs include:
- Initial Design Phase
- Advanced vector construction with regulatory elements and safety features
- Scalable production, from 1L to 200L, using industrial-grade bioreactors
- High-purity purification using chromatography and ultrafiltration
- Quality Control testing, such as sterility testing, endotoxin testing, mycoplasma testing, and potency testing
The company’s integrated platform incorporates advanced technologies such as ÄKTA Pure/Avant FPLC, HPLC, and digital PCR systems to meet the criteria for research and development applications while remaining sufficiently flexible to accommodate diverse project needs and scale-up requirements.
In addition to adenovirus, Creative Biolabs offers lentiviral vectors designed for sustained gene delivery to both dividing and non-dividing cells, ideal for applications in CAR-T cell therapy, stem cell research, and CNS disease research. Furthermore, its AAV vectors mitigate immunogenicity and provide long-term expression suitable for in vivo gene therapy.
For more information or to initiate a custom viral vector project, visit: One-Stop Gene Therapy Development Service – Creative Biolabs
